Search - tctmd.com

Displaying 281 - 300 of 524

Sort: Relevancy | Date

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited

Michael O'Riordan

August 03, 2021

News Daily News

Hospital Stays for Meth-Related HF Skyrocket, as Do Costs

Caitlin E. Cox

July 14, 2021

News Industry News

Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes

June 29, 2021

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

News Daily News

Less Cancer Among HF Patients Taking Statins, Registry Shows

Michael O'Riordan

June 23, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

A New Biomarker to Diagnose Acute Myocarditis?

Todd Neale

June 03, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Daily News

US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines

Todd Neale

May 24, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Daily News

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

Shelley Wood

April 28, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

Advertisement

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited

Hospital Stays for Meth-Related HF Skyrocket, as Do Costs

Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

Less Cancer Among HF Patients Taking Statins, Registry Shows

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

A New Biomarker to Diagnose Acute Myocarditis?

June 2021 News Roundup

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

FDA Approves Dapagliflozin for CKD Patients

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

April 2021 News Roundup

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content